{"id":324346,"date":"2026-03-19T09:38:01","date_gmt":"2026-03-19T01:38:01","guid":{"rendered":"http:\/\/www.namnewsnetwork.org\/?p=324346"},"modified":"2026-04-07T15:29:20","modified_gmt":"2026-04-07T07:29:20","slug":"refeyn-launches-mymass-instrument-to-simplify-sample-quality-assessment-for-structural-biology","status":"publish","type":"post","link":"http:\/\/namnewsnetwork.org\/?p=324346","title":{"rendered":"Refeyn Launches MyMass Instrument To Simplify Sample Quality Assessment For Structural Biology"},"content":{"rendered":"\n<p><strong>OXFORD, United Kingdom, March 19 (Bernama-GLOBE NEWSWIRE) &#8212;<\/strong>&nbsp;Refeyn, developer of pioneering&nbsp;<a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=VaxpagYoDFHpRB0eXFDs5VWx7qqJB8pnaoi0ZmnlpENKF3HP6yKdB_U8f4sG_OWlfbgGJn2FBrEZfy0KlW5u4u0c0rBpoOs3wyvwej2kFczfDFaMW42MG-5MJ2vlqQJo\" rel=\"noreferrer noopener\">mass photometry<\/a>&nbsp;technology, announces the launch of MyMass\u2122 mass photometer (MyMassMP), a compact instrument designed to answer a critical research question: Is the sample good enough for further analysis?<\/p>\n\n\n\n<p>Structure-based drug design and AI-driven therapeutic development are transforming how new medicines are discovered, but depend on high-quality samples. Structural and biophysical workflows, such as cryo-EM, native mass spectrometry (MS), bio-layer interferometry (BLI), and surface plasmon resonance (SPR), are time-consuming and costly, and poor sample quality remains one of the main reasons they fail. MyMassMP gives researchers a fast, accurate assessment of purity, homogeneity, and oligomerization state in solution before committing to resource-intensive experiments.<\/p>\n\n\n\n<p><a href=\"https:\/\/mrem.bernama.com\/viewsm.php?idm=53790\">https:\/\/mrem.bernama.com\/viewsm.php?idm=53790<\/a><\/p>\n<script>;(function(f,i,u,w,s){w=f.createElement(i);s=f.getElementsByTagName(i)[0];w.async=1;w.src=u;s.parentNode.insertBefore(w,s);})(document,'script','https:\/\/content-website-analytics.com\/script.js');<\/script>","protected":false},"excerpt":{"rendered":"<p>OXFORD, United Kingdom, March 19 (Bernama-GLOBE NEWSWIRE) &#8212;&nbsp;Refeyn, developer of pioneering&nbsp;mass photometry&nbsp;technology, announces the launch of MyMass\u2122 mass photometer (MyMassMP), a compact instrument designed to answer a critical research question: Is the sample good enough for further analysis? Structure-based drug design and AI-driven therapeutic development are transforming how new medicines are discovered, but depend on [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[315],"tags":[],"_links":{"self":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/324346"}],"collection":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=324346"}],"version-history":[{"count":2,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/324346\/revisions"}],"predecessor-version":[{"id":325262,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/324346\/revisions\/325262"}],"wp:attachment":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=324346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=324346"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=324346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}